Silk Road Medical, Inc.

Silk Road Medical, Inc. is a medical device company located in Sunnyvale, California, that is focused on reducing the risk of stroke and its devastating impact. The company has pioneered a new approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke.

For more information on the company, visit our website at http://silkroadmed.com/.

The TransCarotid Artery Revascularization (TCAR) Procedure is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. The ENROUTE® Transcarotid Neuroprotection and Stent System are the first and only products specifically designed and indicated for TCAR in high surgical risk patients that need carotid intervention.

For more information about the TCAR procedure and essential prescribing information, please visit http://silkroadmed.com/ifus/.

For more information about carotid artery disease and the risks involved with any intervention (e.g. bleeding, death, myocardial infarction, restenosis, stroke, TIA, vessel dissection, vessel occlusion, etc.), please visit http://silkroadmed.com/disease-and-treatment-options/.

Company’s Keywords:

healthcare, transcarotid artery revascularization, transcarotid therapies, tcar, tcar procedure, carotid artery disease, stroke, stroke prevention, vascular disease, carotid endarterectomy, carotid stenting, carotid revascularization, roadster clinical trial, enroute neuroprotection system, enroute stent system